Phibro Animal Health Corporation

NASDAQ PAHC

Download Data

Phibro Animal Health Corporation Current Part of Long-Term Debt 3 year CAGR for the quarter ending March 31, 2024: 8.35%

Phibro Animal Health Corporation Current Part of Long-Term Debt 3 year CAGR is 8.35% for the quarter ending March 31, 2024, a 334.95% change year over year. Current Part of Long-Term Debt represents the portion of long-term debt that is due within one year. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Phibro Animal Health Corporation Current Part of Long-Term Debt for the quarter ending March 31, 2023 was USD 15.42 M, a 2.80% change year over year.
  • Phibro Animal Health Corporation Current Part of Long-Term Debt for the quarter ending March 31, 2022 was USD 15.00 M, a -36.00% change year over year.
  • Phibro Animal Health Corporation Current Part of Long-Term Debt for the quarter ending March 31, 2021 was USD 23.44 M, a 36.36% change year over year.
  • Phibro Animal Health Corporation Current Part of Long-Term Debt for the quarter ending March 31, 2020 was USD 17.19 M, a 36.85% change year over year.
NASDAQ: PAHC

Phibro Animal Health Corporation

CEO Mr. Jack Clifford Bendheim
IPO Date April 11, 2014
Location United States
Headquarters Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
Employees 1,920
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Similar companies

PROC

Procaps Group SA

NA

NA

EGRX

Eagle Pharmaceuticals Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email